Lakefront Biotherapeutics (LKFT) Gross Margin (2021 - 2026)
Lakefront Biotherapeutics' Gross Margin came in at 24.90% for the quarter ended Jun 30, 2026, down 67.95 percentage points from 92.85% a year earlier and down 1.05 percentage points from the prior quarter.
Lakefront Biotherapeutics (LKFT) Gross Margin (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Lakefront Biotherapeutics reported Gross Margin of -2900.54%, down 2989.69 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at -2573.50%, down 2660.86 percentage points from the prior year.
- Gross Margin has declined in each of the last four years, with a four-year change of -2672.81 percentage points (years ended Dec 2021 to Dec 2025).
- Going back by year, Gross Margin was 87.35% in the year ended Dec 31, 2024 (-5.13 pp), 92.48% in the year ended Dec 31, 2023 (-2.51 pp), 94.99% in the year ended Dec 31, 2022 (-4.31 pp) and 99.30% in the year ended Dec 31, 2021.
- The five-year range for quarterly Gross Margin is -3197.73% (the quarter ended Dec 31, 2025) to 99.78% (the quarter ended Sep 30, 2021).
- Year-over-year, Gross Margin has declined for four consecutive quarters, with an average year-over-year change of -491.18 percentage points over the last seven quarters.
- The fastest year-over-year change in Gross Margin over five years came in the quarter ended Mar 31, 2024 (a gain of 2.02 percentage points), and the weakest in the quarter ended Dec 31, 2025 (a drop of 3293.20 percentage points).
- Business Quant data shows LKFT's Gross Margin at 25.95% (quarter ended Mar 31, 2026), -3197.73% (quarter ended Dec 31, 2025) and 84.70% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Lakefront Biotherapeutics | 1.97 Bn | 1.97 Bn | 3.51 Mn | 24.90% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.90% |
| Mar 31, 2026 | 25.95% |
| Dec 31, 2025 | -3,197.73% |
| Sep 30, 2025 | 84.70% |
| Jun 30, 2025 | 92.85% |
| Mar 31, 2025 | 81.69% |
| Dec 31, 2024 | 95.47% |
| Sep 30, 2024 | 89.49% |
| Mar 31, 2024 | 95.92% |
| Dec 31, 2023 | 96.69% |
| Sep 30, 2023 | 90.62% |
| Jun 30, 2023 | 92.96% |
| Mar 31, 2023 | 93.90% |
| Sep 30, 2022 | 98.21% |
| Jun 30, 2022 | 98.12% |
| Mar 31, 2022 | 97.86% |
| Sep 30, 2021 | 99.78% |
| Jun 30, 2021 | 99.96% |
| Mar 31, 2021 | 99.97% |
Lakefront Biotherapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=LKFT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "LKFT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=LKFT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();